Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (11-20 of 1,111) with videos related to

Pageof 112
Sort By:
La Revue Du Praticien|May 17, 2003
[Acute coronary syndrome with ST-segment elevation]Olivier Varenne, Philippe Gabriel Steg
Circulation|August 4, 2025
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation Receiving Oral Antiplatelet Therapy: Definitely Safe, but How Effective?Philippe Gabriel Steg, Jules Mesnier
Circulation|March 28, 2022
Atrial Fibrillation Screening: The Tools Are Ready, But Should We Do It?Fabrice Extramiana, Philippe Gabriel Steg
European Heart Journal|June 5, 2008
Stroke is a coronary heart disease risk equivalent: implications for future clinical trials in secondary stroke preventionPierre Amarenco, Philippe Gabriel Steg
JAMA|April 2, 2008
Does PERISCOPE provide a new perspective on diabetic treatment?Philippe Gabriel Steg, Michel Marre
European Heart Journal|October 28, 2008
Devices to protect against embolization during primary angioplasty for ST-segment elevation myocardial infarction: the good, the bad and the uglyP Gabriel Steg, Gregory Ducrocq
Circulation|November 16, 2022
Do We Need Ischemia Testing to Monitor Asymptomatic Patients With Chronic Coronary Syndromes?Philippe Gabriel Steg, John Kikoïne
European Journal of Preventive Cardiology|February 8, 2025
Navigating PCI Risks in Cancer PatientsJules Mesnier, Philippe Gabriel Steg
Archives of Cardiovascular Diseases|September 16, 2015
Treating coronary artery disease in patients with a history of cerebrovascular diseaseGregory Ducrocq, Philippe Gabriel Steg
Journal of the American College of Cardiology|December 19, 2003
Circadian variations in outcome of primary percutaneous coronary interventionPh Gabriel Steg, Philippe Garot
Pageof 112

Showing results (11-20 of 1,111) with videos related to

Sort By:
Pageof 112
La Revue Du Praticien|May 17, 2003
[Acute coronary syndrome with ST-segment elevation]Olivier Varenne, Philippe Gabriel Steg
Circulation|August 4, 2025
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation Receiving Oral Antiplatelet Therapy: Definitely Safe, but How Effective?Philippe Gabriel Steg, Jules Mesnier
Circulation|March 28, 2022
Atrial Fibrillation Screening: The Tools Are Ready, But Should We Do It?Fabrice Extramiana, Philippe Gabriel Steg
European Heart Journal|June 5, 2008
Stroke is a coronary heart disease risk equivalent: implications for future clinical trials in secondary stroke preventionPierre Amarenco, Philippe Gabriel Steg
JAMA|April 2, 2008
Does PERISCOPE provide a new perspective on diabetic treatment?Philippe Gabriel Steg, Michel Marre
European Heart Journal|October 28, 2008
Devices to protect against embolization during primary angioplasty for ST-segment elevation myocardial infarction: the good, the bad and the uglyP Gabriel Steg, Gregory Ducrocq
Circulation|November 16, 2022
Do We Need Ischemia Testing to Monitor Asymptomatic Patients With Chronic Coronary Syndromes?Philippe Gabriel Steg, John Kikoïne
European Journal of Preventive Cardiology|February 8, 2025
Navigating PCI Risks in Cancer PatientsJules Mesnier, Philippe Gabriel Steg
Archives of Cardiovascular Diseases|September 16, 2015
Treating coronary artery disease in patients with a history of cerebrovascular diseaseGregory Ducrocq, Philippe Gabriel Steg
Journal of the American College of Cardiology|December 19, 2003
Circadian variations in outcome of primary percutaneous coronary interventionPh Gabriel Steg, Philippe Garot
Pageof 112